Date: Thursday, March 27
Time: 9:00 (PDT), 12:00 (EDT), 16:00 (GMT)
This WuXi AppTec event is complementary and open to life science professionals globally.
Online Registration, Please Click Here.
Alzheimer’s, schizophrenia and other central nervous system disorders are some of the biggest unmet medical needs facing healthcare today with enormous burden to society. Aging populations are set to further increase the need for safe and effective drugs. Biopharma has faced challenges in neuroscience R&D, but through recent scientific advances and collaborative efforts, the field is now poised for revitalization. In this complimentary live webinar, WuXi brings together key thought leaders and players to discuss the new resurgence of neuroscience R&D.
Click Here for Speaker Biography.
Steve Paul, MD Venture Partner • Third Rock Ventures
Mark Shearman, PhD Senior VP of Neurology Gobal Research and Development• EMD Serono
Craig Lindsley, PhD Co-Director • The Vanderbilt Center for Neuroscience Drug Discovery
Jay Kranzler, MD, PhD Global Head of Neuroscience and Pain & SensoryDisorders External R&D Innovation • Pfizer
Richard Soll, PhD Senior VP of International Discovery Service Unit • WuXi AppTec (moderator)
Submit your questions for the speakers in advance during registration. Tweet your questions to us #WuXiNeuro.